Biopharmaceuticals are one of the key growth drivers of the pharmaceutical and biotechnology industries. Lonza has strong capabilities in large and small molecules, peptides, amino acids and niche bioproducts which play an important role in the development of novel medicines and healthcare products. Lonza is also the world leader in microbial control providing innovative, chemistry-based and related solutions to destroy or to selectively inhibit the growth of harmful microorganisms. Its activities encompass the areas of water treatment, personal care, health and hygiene, industrial preservation, materials protection, and wood treatment. In addition, Lonza is a leader in cell-based research, endotoxin detection and cell therapy manufacturing. Furthermore, the company is a leading provider of value chemical and biotech ingredients to the nutrition and agro markets.
Company Growth (employees)
Type
Public
HQ
Basel, CH
Founded
1897
Size (employees)
10,342 (est)+5%
Website
lonza.com
Lonza was founded in 1897 and is headquartered in Basel, CH

Lonza Office Locations

Lonza has an office in Basel
Basel, CH (HQ)
38 Münchensteinerstrasse

Lonza Financials and Metrics

Lonza Financials

EUR

Market capitalization (27-Oct-2017)

14.2 b

Closing share price (27-Oct-2017)

226
Lonza's current market capitalization is €14.2 b.
Show all financial metrics

Lonza Market Value History

Lonza's Web-traffic and Trends

Lonza Online and Social Media Presence

Lonza News and Updates

Medium-chain Triglycerides Market, by Fatty Acid Type, Application, and Geography - Trends and Forecast till 2025

The global medium-chain triglycerides market was valued at US$ 1,309.8 million in 2016 and is expected to exhibit a CAGR of 6.55%, in terms of revenue, during 2017 – 2025. Key factors such as favorable growth in sport activities across region. Posted via Industry Today. Follow us on Twitter @Industr…

Global 3D Cell Culture Market 2017 - Industry Analysis, Size, Share, Strategies and Forecast to 2022

Global 3D Cell Culture Market is accounted for $375.25 million in 2015 and is expected to reach $1520.15 million by 2022 growing at a CAGR of 22.1% during the forecast period. Posted via Industry Today. Follow us on Twitter @IndustryToday

Media sera and Reagents- Cell culture Market by Application - Model System, Cancer Research, Virology and Forecast to 2027

Global Cell Culture market by Type (Media, Sera and Reagents), by Applications (model system, cancer research, virology), by end users - Forecast to 2027 Posted via Industry Today. Follow us on Twitter @IndustryToday

Complete Research on Healthcare BPO Market and Global Foresight to 2023

Healthcare Business Process Outsourcing (BPO) Market Information: By Service (Pharmaceutical, Payer, Provider), By Region (Americas (US, Canada), Europe (Germany, France), Asia (China, India) Pacific, Middle East & Africa) – Trends and Forecast till 2023 Posted via Industry Today. Follow us on T…

GMP Cell Banking Services Market to Progress at 14.3% CAGR During 2017–2025

Persistence Market Research has announced the addition of the “Global Market Study on GMP Cell Banking Services: Mammalian Cell Type Segment Revenue Projected to Grow 3.2x by 2025 End as Compared to that in 2017" report to their offering. Posted via Industry Today. Follow us on Twitter @IndustryToda…

Biologics Safety Testing Market Mark Revenue of US$ 4.36 Bn through 2017-2022

Persistence Market Research has announced the addition of the “Global Market Study on Biologics Safety Testing: Endotoxin Tests to Witness Surplus Demand during 2017-2022"report to their offering. Posted via Industry Today. Follow us on Twitter @IndustryToday
Show more

Lonza Company Life and Culture

You may also be interested in